Literature DB >> 8290381

Perinatal predictors of ocular morbidity in school children who were very low birthweight.

F G McGinnity1, H L Halliday.   

Abstract

Two hundred children from one neonatal intensive care unit (NICU), who were very low birthweight (VLBW), were examined at approximately 9 years of age and compared with a control group of normal birthweight children. Visual morbidity was significantly higher among children who were very low birthweight. Binocular visual acuity of 6/9 or worse was noted in 21 (10.5%), strabismus in 38 (19%) and regressed retinopathy of prematurity (ROP) in 13 (6.7%) of these children. A history of seizures in the perinatal period was highly correlated with poor visual acuity. Independently significant factors associated with strabismus included clinically diagnosed intraventricular haemorrhage, a maternal history of neonatal death, transfer from another hospital, bronchopulmonary dysplasia and necrotising enterocolitis. Perinatal variables that correlated with regressed ROP included birthweight, time from birth to admission to the NICU, necrotising enterocolitis and a history of maternal smoking during the pregnancy. When screening for ocular abnormalities among children who were born preterm, particular attention should be given to children with these risk factors.

Entities:  

Mesh:

Year:  1993        PMID: 8290381     DOI: 10.1111/j.1365-3016.1993.tb00423.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  3 in total

1.  Visual impairment in very low birthweight children.

Authors:  A Powls; N Botting; R W Cooke; G Stephenson; N Marlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

Review 2.  Epidemiology of visual impairment in Britain.

Authors:  J S Rahi; C Dezateux
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

3.  Ocular significance of intraventricular haemorrhage in premature infants.

Authors:  M O'Keefe; N Kafil-Hussain; I Flitcroft; B Lanigan
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.